ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,943 | +23.2% | 153,618 | +69.0% | 0.00% | – |
| Q2 2023 | $325,476 | +47.9% | 90,915 | -9.9% | 0.00% | – |
| Q1 2023 | $220,080 | +10.8% | 100,954 | +511.6% | 0.00% | – |
| Q4 2022 | $198,579 | -44.1% | 16,507 | -69.9% | 0.00% | – |
| Q3 2022 | $355,000 | +173.1% | 54,902 | +93.6% | 0.00% | – |
| Q2 2022 | $130,000 | -78.6% | 28,363 | -59.6% | 0.00% | – |
| Q1 2022 | $607,000 | -63.7% | 70,183 | -40.0% | 0.00% | – |
| Q4 2021 | $1,672,000 | +284.4% | 117,034 | +492.0% | 0.00% | – |
| Q3 2021 | $435,000 | -7.2% | 19,768 | -43.6% | 0.00% | – |
| Q2 2021 | $469,000 | +133.3% | 35,055 | +77.4% | 0.00% | – |
| Q1 2021 | $201,000 | – | 19,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |